1. Home
  2. RLYB vs RVP Comparison

RLYB vs RVP Comparison

Compare RLYB & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • RVP
  • Stock Information
  • Founded
  • RLYB 2018
  • RVP 1994
  • Country
  • RLYB United States
  • RVP United States
  • Employees
  • RLYB N/A
  • RVP N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • RVP Medical/Dental Instruments
  • Sector
  • RLYB Health Care
  • RVP Health Care
  • Exchange
  • RLYB Nasdaq
  • RVP Nasdaq
  • Market Cap
  • RLYB 13.3M
  • RVP 20.5M
  • IPO Year
  • RLYB 2021
  • RVP 2001
  • Fundamental
  • Price
  • RLYB $0.29
  • RVP $0.75
  • Analyst Decision
  • RLYB Hold
  • RVP
  • Analyst Count
  • RLYB 4
  • RVP 0
  • Target Price
  • RLYB $15.00
  • RVP N/A
  • AVG Volume (30 Days)
  • RLYB 93.6K
  • RVP 38.0K
  • Earning Date
  • RLYB 05-08-2025
  • RVP 05-19-2025
  • Dividend Yield
  • RLYB N/A
  • RVP N/A
  • EPS Growth
  • RLYB N/A
  • RVP N/A
  • EPS
  • RLYB N/A
  • RVP N/A
  • Revenue
  • RLYB $848,000.00
  • RVP $33,049,532.00
  • Revenue This Year
  • RLYB N/A
  • RVP N/A
  • Revenue Next Year
  • RLYB N/A
  • RVP N/A
  • P/E Ratio
  • RLYB N/A
  • RVP N/A
  • Revenue Growth
  • RLYB N/A
  • RVP N/A
  • 52 Week Low
  • RLYB $0.22
  • RVP $0.56
  • 52 Week High
  • RLYB $2.00
  • RVP $1.22
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 35.98
  • RVP 57.13
  • Support Level
  • RLYB $0.29
  • RVP $0.70
  • Resistance Level
  • RLYB $0.33
  • RVP $0.76
  • Average True Range (ATR)
  • RLYB 0.02
  • RVP 0.04
  • MACD
  • RLYB 0.02
  • RVP 0.00
  • Stochastic Oscillator
  • RLYB 56.47
  • RVP 91.67

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: